Management of epilepsy and pregnancy

Journal of Postgraduate Medicine

Volumn 52, Issue 1, 2006, Pages 57-64

  Thomas, S V ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Antenatal ultrasonography; Antiepileptic drug; Congenital malformation; Epilepsy; Gender issues; Pregnancy; Prevention; Reproductive dysfunction; Teratogenesis; Treatment

Indexed keywords

ALPHA FETOPROTEIN; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; ENZYME INDUCING AGENT; ESTROGEN; ETIRACETAM; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PROGESTERONE; SEX HORMONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VITAMIN K GROUP; ZONISAMIDE;

BREAST FEEDING; CARDIOVASCULAR MALFORMATION; CESAREAN SECTION; CLEFT LIP; CLEFT PALATE; CLINICAL TRIAL; CLUBFOOT; CRANIOFACIAL MALFORMATION; CRYPTORCHISM; DIAPHRAGM HERNIA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; EPILEPSY; ESOPHAGUS ATRESIA; FALLOT TETRALOGY; GASTROINTESTINAL MALFORMATION; GESTATION PERIOD; HEART ATRIUM SEPTUM DEFECT; HEART SINGLE VENTRICLE; HEART VENTRICLE SEPTUM DEFECT; HIP DISLOCATION; HUMAN; HYDRONEPHROSIS; HYPERTROPHIC PYLORUS STENOSIS; HYPOSPADIAS; INFERTILITY; INGUINAL HERNIA; KIDNEY AGENESIS; LUNG ATRESIA; NEURAL TUBE DEFECT; NEWBORN DISEASE; OMPHALOCELE; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; PATENT DUCTUS ARTERIOSUS; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL CARE; PRENATAL EXPOSURE; PRESCRIPTION; PUERPERIUM; REVIEW; SKELETON MALFORMATION; TERATOGENICITY; TREATMENT FAILURE; UMBILICAL HERNIA; UROGENITAL TRACT MALFORMATION;

ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; POSTPARTUM PERIOD; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK;

EID: 33644999455     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Sridharan R, Murthy BN. Prevalence and pattern of epilepsy in India. Epilepsia 1999;40:631-6.
2. World Population Prospects: The 2004 Revision and World Urbanization Prospects: The 2003 Revision, http://esa.un.org/unpp, accessed on 27 September 2005; 4:30:25 AM.
3. Thomas SV, Deetha TD, Kurup JR, Reghunath B, Radhakrishnan K, Sarma PS. Pregnancy among women with epilepsy. Ann Indian Acad Neurology 1999;2:123-8.
4. Grudzinska B, Kazibutowska Z, Mierzwa E, Pierzchala K, Rosciszewska D, Zawisza L. Fertility in the population of women with epilepsy. Neurol Neurochir Pol 1979;13:497-502.
5. Krauss GL, Brandt J, Campbell M, Plate C, Summerfield M. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians. Neurology 1996;46:1534-9.
6. Russell AJ, Macpherson H, Cairnie V, Brodie MJ. The care of pregnant women with epilepsy: a survey of obstetricians in Scotland. Seizure 1996;5:271-7.
7. Herzog AG. Reproductive endocrine considerations and hormonal therapy for women with epilepsy. Epilepsia 1991;32:S27-33.
8. Reghunath B. Neuroendocrine aspects of epilepsy and pregnancy in Sanjeev V. Thomas (ed) Proceedings of Workshop on fertility and pregnancy among women with epilepsy. Kerala Registry of Epilepsy and pregnancy, Trivandrum. 1998;7-11.
9. Marcus EM, Watson CW, Goldman PL. Effects of steroids on cerebral electrical activity. Epileptogenic effects of conjugated estrogens and related compounds in the cat and rabbit. Arch Neurol 1966;15:521-32.
10. Nicoletti F, Speciale C, Sortino MA, Summa G, Caruso G, Patti F, et al. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia 1985;26:252-7.
11. Logothetis J, Harner R, Morrell F, Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology (Minneap) 1958;9:352-60.
12. Backstrom T, Zetterlund B, Blom S, Romano M. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol Scand 1984;69:240-8.
13. Commission on classification and terminology of the International League against epilepsy1989 Proposal for revised classification of epilepsies and epileptic sydromes. Epilepsia 1989;30:389-99.
14. Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 1975;16:99-110.
15. Thomas SV, Devi CC, Radhakrishnan K, Joshua CS. Seizure pattern during pregnancy and puerperium among women with epilepsy. Epilepsia 2000;41:198-9.
16. Morrell MJ, Montouris GD. Reproductive disturbances in patients with epilepsy Cleve Clin J Med 2004;71:S19-24.
17. Artama M, Isojarvi JI, Raitanen J, Auvinen A. Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland. Am J Epidemiol 2004;159:1057-63.
18. Cramer JA, Jones EE. Reproductive function in epilepsy. Epilepsia 1991;32:S19-26.
19. Polson DW. Polycystic ovary syndrome and epilepsy - a gynaecological perspective. Seizure 2003;12:397-402.
20. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risksrelated to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
21. Meo R, Bilo L. Polycystic ovary syndrome and epilepsy: a review of the evidence. Drugs 2003;63:1185-227.
22. Isojarvi JI, Rattya J, Myllyla VV, Knip M, Koivunen R, Pakarinen AJ, et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998;43:446-51.
23. Bauer J, Isojarvi JI, Herzog AG, Reuber M, Polson D, Tauboll E, et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatr 2002;73:121-5.
24. Sindhu K, Thomas SV, Ajaykumar B, Sylaja PN, Sulekhadevi PB, Jacob S. Complications of pregnancy and delivery in women with epilepsy. Epilepsia 2005;46:84.
25. Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 1972;2:839-43.
26. Anderman E, Dansky L, Kinch RA. Complications of pregnancy, labor and delivery in epileptic women. In: Janz, D, Dam M, Richens A, Bossi L, Helge H, Schmidt D. (editors) in Epilepsy, pregnancy and child. Raven Press: New York; 1982. p. 61-74.
27. Richmond JR, Krishnamoorthy P, Andermann E, Benjamin A. Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol 2004;190:371-9.
28. Olafsson E, Hallgrimsson JT, Hauser WA, Ludvigsson P, Gudmundsson G. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 1998;39:887-92.
29. Hiilesmaa VK. Pregnancy and birth in women with epilepsy. Neurol 1992:42:8-11.
30. Teramo K, Hiilesmaa V, Bardy A, Saarikoski S. Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med 1979;7:3-6.
31. Diaz Romero RM, Garza MS, Molina DG. Facial anthorpometric measurements in offsprings of epileptic mothers. Epilepsia 1999;40:194.
32. Janz D, Fuchs U. Are anti epileptic drugs harmful during pregnancy? Dtsch Med Wschr 1964;89:241-8.
33. Meadow SR. Anticonvulsant drugs and congenital abnormalities. Lancet 1968;2:1296.
34. Janz D. On Major Malformations and Minor Anomalies in the offspring of parents with epilepsy: Review of the literature. In: Epilepsy, Pregnancy, and the Child. D. Janz, M. Dam, A. Richens et al (editors). Raven Press: New York; 1982. p. 211-22.
35. Samren EB, Van Duijn CM, Koch S, Hiilesmaa VK, Klepel H, Bardy AH, et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: A joint european prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997;38:981-90.
36. Wide K, Winbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 2004;93:174-6.
37. Holmes LB, Wyszynski DF, Lieberman E. The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 2004;61:673-8.
38. Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. Antiepileptic Drug Pregnancy Registry. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005;64:961-5.
39. Meischenguiser R, D'Giano CH, Ferraro SM. Oxcarbazepine in pregnancy: clinical experience in Argentina. Epilepsy Behav 2004;5:163-7.
40. Montouris G. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin 2005;21:693-701.
41. Cunnington M, Tennis P. International Lamotrigine Pregnancy registry Scientific Advisory Committee. Lamotrigine and the risk of malformations in pregnancy. Neurol 2005;64:955-60.
42. Nicolson A, Appleton RE, Chadwick DW, Smith DF. The relationship between treatment with valproate, lamotrigine and topiramate and the prognosis if the idiopathic generalized epilepsies. JNNP 2004;75:75-9.
43. de Haan GJ, Edelbroek P, Segers J, Engelsman M, Lindhout D, Devile-Notschaele M, et al. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology 2004;63:571-3.
44. Liporace J, Kao A, D'Abreu A. Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav 2004;5:102-5.
45. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000;41:709-13.
46. Sabers A, Dam M, Rogvi-Hansen B, Boas J, Sidenius P, Laue Friis M, et al. Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand 2004;109:9-13.
47. Morrell MJ. Guidelines for the care of women with epilepsy. Neurology 1998;51:521-7.
48. Craid J, Russell A, Morrison P, Robertson I, Parson L, Morrow J. The antiepileptic drugs in pregnancy a registry in the UK to determine their safety. Epilepsia 1999;40:196.
49. Tomson T, Perucca E, Battino D. Navigating toward Fetal and Maternal Health: The Challenge of Treating Epilepsy in Pregnancy. Epilepsia 2004;45:1171-5.
50. Ohman I, Vitols S, Luef G, Soderfeldt B, Tomson T. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 2002;43:1157-60.
51. Briggs DE, French JA. Levetiracetam safety profiles and tolerability in epilepsy patients. Expert Opin Drug Saf 2004;3:415-24.
52. Long L. Levetiracetam monotherapy during pregnancy: a case series. Epilepsy Behav 2003;4:447-8.
53. Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA. Neuropsychological effects of exposure to anti convulstant medication in utero. Neurol 2005;64:949-54.
54. Thomas SV, Indrani L, Devi GC, Jacob S, Beegum J, Jacob PP, et al. Pregnancy in women with epilepsy: preliminary results of Kerala registry of epilepsy and pregnancy. Neurol India 2001;49:60-6.
55. Cornelissen M, Steegers-Theunissen R, Kollee L, Eskes T, Motohara K, Monnens LL. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 1993;168:884-8.
56. Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003;61:S35-42.
57. Ohman I, Vitols S, Luef G, Soderfeldt B, Tomson T. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations Epilepsia 2002;43:1157-60.
58. Bar-Oz B, Nulman I, Koren G, Ito S. Anticonvulsants and breast feeding: a critical review. Paediatr Drugs 2000;2:113-26.
59. Ohman I, Vitols S, Luef G, Soderfeldt B, Tomson T. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 2002;43:1157-60.
60. Bulau P, Paar WD, von Unruh GE. Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother. Eur J Clin Pharmacol 1988;34:311-3.
61. Kawada K, Itoh S, Kusaka T, Isobe K, Ishii M. Pharmacokinetics of zonisamide in perinatal period. Brain Dev 2002;24:95-7.